It calling the board "prestigious" another (lame) attempt at humor on your part? I wouldn't call the board prestigious, but rather liken it to a crucible where a mixture of skepticism and highly critical challenges to data and comments by investors and CEOs are subjected to high heat to burn off hype and misinformation. What is left are the ashes that one must sort through to get closer to the substances of value.
Your post is long and contains a lot of irrelevant blather and classic newbie mistakes, so has little value. I could go through it in detail but just one example is your slavish and apparently blind faith in Dr. Garnick. I am pleased for Dr. Garnick that he has had a long an successful career at Genetech. He is probably quite wealthy too. What does that have to do with how Bavi will ultimately perform in NSCLC data?
Market Data 
Markets 
AI
